Acute myocardial infarction
|
0.010 |
Biomarker
|
disease |
BEFREE |
The ERR for MI (MI-ERR) in 2011.
|
28445559 |
2017 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, we found that CAT-1 protein levels were higher in HBV-related HCC carcinomatous tissues than in para-cancerous tumor tissues, and that CAT-1 promoted HCC cell growth, proliferation, and metastasis.
|
28977838 |
2017 |
Hypertensive disease
|
0.040 |
Biomarker
|
group |
BEFREE |
The results of the present study indicate that miR-145 functions as a key mediator in the pathogenesis of hypertension via targeting SLC7A1, which suggests that miR-145 is a potential target for the treatment of hypertension.
|
29434681 |
2018 |
Malignant neoplasm of thyroid
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
After adjusting for attained age, sex, birth year, body mass index and pack-years smoked, we found no association between thyroid dose and thyroid cancer risk (ERR/100 mGy = -0.05, 95% CI <-0.10, 0.34).
|
29355960 |
2018 |
Bronchitis, Chronic
|
0.010 |
Biomarker
|
disease |
BEFREE |
Two definitions of CB using CAT 1/2 scores and SGRQ questions were used to phenotype CB among the study patients.
|
29942122 |
2018 |
Coughing
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The present study defined CB using CAT 1 and 2 scores and the questions on the severity of cough and sputum from the SGRQ.
|
29942122 |
2018 |
Thyroid Neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
After adjusting for attained age, sex, birth year, body mass index and pack-years smoked, we found no association between thyroid dose and thyroid cancer risk (ERR/100 mGy = -0.05, 95% CI <-0.10, 0.34).
|
29355960 |
2018 |
Bicuspid aortic valve
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
BAV TAA samples showed an increased concentration of putrescine and spermidine vs. TAV and donor samples, together with a decreased mRNA level of polyamine anabolic enzymes and of the putative polyamine transporter SLC7A1/CAT-1.
|
29147966 |
2018 |
Thyroid carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
After adjusting for attained age, sex, birth year, body mass index and pack-years smoked, we found no association between thyroid dose and thyroid cancer risk (ERR/100 mGy = -0.05, 95% CI <-0.10, 0.34).
|
29355960 |
2018 |
Cardiovascular Diseases
|
0.110 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Trans-ethnic association study of blood pressure determinants in over 750,000 individuals.
|
30578418 |
2019 |
Malignant neoplasm of stomach
|
0.020 |
Biomarker
|
disease |
BEFREE |
In conclusion, these results suggested that CAT1 promotes the tumorigenesis and progression of GC by negatively regulating miR-219-1.
|
31478245 |
2019 |
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
In conclusion, these results suggested that CAT1 promotes the tumorigenesis and progression of GC by negatively regulating miR-219-1.
|
31478245 |
2019 |
Stomach Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
In conclusion, these results suggested that CAT1 promotes the tumorigenesis and progression of GC by negatively regulating miR-219-1.
|
31478245 |
2019 |
Virus Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
CAT1/SLC7A1 acts as a cellular receptor for bovine leukemia virus infection.
|
31648581 |
2019 |
BLV Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
These findings provide insights for BLV infection and for developing new strategies for treating BLV and preventing its spread.-Bai, L., Sato, H., Kubo, Y., Wada, S., Aida, Y. CAT1/SLC7A1 acts as a cellular receptor for bovine leukemia virus infection.
|
31648581 |
2019 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
STAT3 Targets <i>ERR-α</i> to Promote Epithelial-Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells.
|
31427441 |
2019 |